Female Reproductive System Squamous Cell Carcinoma

Female Reproductive System Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

107 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 29
Recruiting: 14
Ph III recruiting: 1
Growth YoY: —
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 15.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07804966	Sac-TMT in Vaginal and Vulvar Cancers(ARCANA)	not yet recruiting	Phase 2	48	Latin American Cooperative Oncology GroupOTHER	1	Sep 4, 2026	clinicaltrials
NCT07679841	Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients(COLOMBE)	not yet recruiting	Phase 1 / Phase 2	50	Centre Leon BerardOTHER	1	Jul 1, 2026